CN1308016C - 滋补酒 - Google Patents
滋补酒 Download PDFInfo
- Publication number
- CN1308016C CN1308016C CNB2005100642288A CN200510064228A CN1308016C CN 1308016 C CN1308016 C CN 1308016C CN B2005100642288 A CNB2005100642288 A CN B2005100642288A CN 200510064228 A CN200510064228 A CN 200510064228A CN 1308016 C CN1308016 C CN 1308016C
- Authority
- CN
- China
- Prior art keywords
- wine
- tonic wine
- fructus lycii
- herb gynostemmae
- gynostemmae pentaphylli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000009469 supplementation Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 33
- 230000001256 tonic effect Effects 0.000 claims abstract description 18
- 241001251068 Formica fusca Species 0.000 claims description 20
- 241001620634 Roger Species 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims 7
- 230000000694 effects Effects 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 240000005373 Panax quinquefolius Species 0.000 abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 abstract description 2
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 2
- 229930182490 saponin Natural products 0.000 abstract description 2
- 150000007949 saponins Chemical class 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 241000257303 Hymenoptera Species 0.000 abstract 3
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 239000008121 dextrose Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229930187479 gypenoside Natural products 0.000 description 11
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 11
- 230000036541 health Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 229930182494 ginsenoside Natural products 0.000 description 5
- 229940089161 ginsenoside Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 206010038019 Rectal adenocarcinoma Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 206010007776 catatonia Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 201000001281 rectum adenocarcinoma Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- -1 triterpenoid compound Chemical class 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种滋补酒,它每1000ml白酒中含有下列重量中药原料:蚂蚁1-100g、枸杞子50-200g、西洋参1-50g、绞股蓝50-200g。所述白酒为55度粮食酿造优质白酒。所述蚂蚁为拟黑多刺蚁。本发明配伍科学,以酒行药势,以酒助药物有效成分的析出,经测定,每100ml本发明滋补酒中含有粗多糖(以葡萄糖计)0.51mg,总皂甙(以人参皂甙Re计)0.42mg,从而能够很好地调节人体免疫功能,达到怡气健身、壮阳补肾、增强体力之目的。适宜于免疫力低下者。
Description
技术领域
本发明涉及一种保健酒,具体地说,涉及一种调节人体免疫功能、怡气健身、壮阳补肾、增强体力的滋补酒。
背景技术
酒有多种,其性味功效大同小异。一般而论,酒性温而味辛,温者能祛寒、疏导,辛者能发散、疏导,所以酒能疏通经脉、行气和血、蠲痹散结、温阳祛寒,能疏肝解郁、宣情畅意;又酒为谷物酿造之精华,故还能补益肠胃。此外,酒能杀虫驱邪、辟恶逐秽。《博物志》有一段记载:王肃、张衡、马均三人冒雾晨行。一人饮酒,一人饮食,一人空腹;空腹者死,饱食者病,饮酒者健。这表明“酒势辟恶,胜于作食之效也。”
酒与药物的结合是饮酒养生的一大进步。酒之于药主要有三个方面的作用:1.酒可以行药势。古人谓“酒为诸药之长”。酒可以便药力外达于表而上至于颠,使理气行血药物的作用得到较好的发挥,也能使滋补药物补而不滞。2.酒有助于药物有效成分的析出。酒是一种良好的有机溶媒,大部分水溶性物质及水不能溶解、需用非极性溶媒溶解的某些物质,均可溶于酒精之中。中药的多种成分都易于熔解于酒精之中。酒精还有良好的通透性,能够较容易地进入药材组织细胞中,发挥溶解作用,促进置换和扩散,有利于提高浸出速度和浸出效果。3.酒还有防腐作用。一般药酒都能保存数月甚至数年时间而不变质,这就给饮酒养生者以极大的便利。
随着人们生活水平的提高,人们对自身身体保健越来越重视,保健酒的需求量越来越大。市场上保健酒产品琳琅满目。保健酒因其配方不同,口味各不相同,其作用也各不相同,往往存在鱼目混珠的现象,尤其是目前还没有一种能够很好地调节人体免疫功能,达到怡气健身、壮阳补肾、增强体力之目的的保健酒。
发明内容
本发明需要解决的技术问题就在于克服现有保健酒在调节人体免疫功能方面存在的不足,提供一种滋补酒,它能够很好地调节人体免疫功能,达到怡气健身、壮阳补肾、增强体力之目的。
为解决上述问题,本发明采用如下技术方案:
本发明保健酒,它是每1000ml白酒中含有下列重量中药原料:
蚂蚁1-100g、枸杞子50-200g、西洋参1-50g、绞股蓝50-200g。
优选地,本发明每1000ml白酒中含有下列重量中药原料:
蚂蚁1-20g、枸杞子50-80g、西洋参1-10g、绞股蓝50-80g。
进一步优选地,本发明每1000ml白酒中含有下列重量中药原料:
蚂蚁10g、枸杞子65g、西洋参5g、绞股蓝65g。
或者,优选地,本发明每1000ml白酒中含有下列重量中药原料:
蚂蚁20-60g、枸杞子80-160g、西洋参10-40g、绞股蓝80-160g。
进一步优选地,本发明每1000ml白酒中含有下列重量中药原料:
蚂蚁50g、枸杞子150g、西洋参25g、绞股蓝150g。
或者,优选地,每1000ml白酒中含有下列重量中药原料:
蚂蚁60-100g、枸杞子160-200g、西洋参40-50g、绞股蓝160-200g。
进一步优选地,本发明每1000ml白酒中含有下列重量中药原料:
蚂蚁80g、枸杞子180g、西洋参45g、绞股蓝180g。
本发明白酒为55度粮食酿造优质白酒。
本发明所用蚂蚁优选为拟黑多刺蚁。
本发明中,蚂蚁,又名蚍蜉,药用名称为“玄驹”,属完全变态的昆虫。蚂蚁性味成、平、有毒性。药用价值较高,蚂蚁的药用价值较高,具有抗风湿、抗炎、杀菌、抑菌、抗癌、抗过敏、护肝、平喘、镇痛、镇静、壮阳、滋阴、解毒等功能。对类风湿性关节炎、风湿性关节炎、恶性肿瘤、慢性肝炎、肺结核、阳萎、病后脱发、神经官能症等均有良好的医疗效果。
本发明优选的拟黑多刺蚁作为传统养生资源,文字记载已有三千多年的历史。拟黑多刺蚁含有丰富的蛋白质,其含量高达40%-55%,少数可达67%以上。其所含19种氨基酸中,有8种是人体必需氨基酸即:苏氨酸、苯丙氨酸、缬氨酸、异亮氨酸、亮氨酸、棘氨酸、蛋氨酸、色氨酸等。并含维生素A、维生素B1、B2、B12和C、D、E和钙、铁、铬、镁、锌、碘、硒等28种微量元素,其中以锌的含量最多,达到每千克含锌230mg-280mg。最为特别的是拟黑多刺蚁含有多种酶类和辅酶、草体蚁酸、淄族类化合物、三萜类化合物、蚁酸,同时含有大量的高能磷化物ATP,《本草纲目》记载;拟黑多刺蚁“扶正祛邪、补肾强身、活血化淤、延年益寿。食之益气力、泽颜色。”《中药大词典》记载,拟黑多刺蚁对抗衰老有奇效。
拟黑多刺蚁的主要功能有:
1、骨关节疾病:类风湿、风湿性关节炎、肩周炎、腰腿痛。
2、心脑血管疾病:冠心病、脑血栓后遗症、心绞痛、心肌炎。
3、泌尿系统疾病:肾炎、阳痿、早泄、性冷淡。
4、消化系统疾病:胃炎、消化不良、胆囊炎、肝炎、肝腹水、肝硬化。
5、神经系统疾病:神经衰弱、植物神经功能紊乱、失眠、头痛。
6、其他疾病:糖尿病、红斑狼疮、硬皮病、少白头、牙齿脱落、癌症术后。
本发明中,枸杞子叫枸杞果,产于天津、河南、河北、山西、宁夏等地。枸杞子味甘、性平,具有滋阴补血,益精明目等作用。中医常用于治疗因肝肾阴虚或精血不足而引起的头昏、目眩腰膝酸软、阳痿早泄、遗精、白带过多及糖尿病等症。
现代医学研究证明,枸杞子内含枯可胺A、甜菜碱及多种维生素、氨基酸等。这些物质具有降低血压、降低胆固醇、软化血管、降低血糖、保护肝脏、提高人体免疫功能等作用。因此,枸杞子还是一味预防动脉硬化、糖尿病、肝硬化以及增强机体抗病能力的良药。
本发明中,西洋参(Panax quinquefolium L.),又名花旗参,具有很高的药用价值,其药用价值来源于其中的各种人参皂甙。它可提升人体免疫力,并抑制癌细胞成长,能保护细胞膜和防止细胞老化,扩张血管,降低血压和血糖,提高肝细胞蛋白质和DNA合成,显著抑制宫颈癌细胞生长,对于人体抗疲劳、抗衰老有显著疗效。
本发明中,绞股蓝,中药名为七叶胆,又叫小苦药、公罗锅底,小母猪油等。在日本,被誉为“福音草”为葫芦科,属多年生草质藤本植物。绞股蓝主要含绞股蓝皂甙、多种氨基酸、矿物质以及维生素C。目前,科学家已从绞股蓝中分离鉴定了82种与人参皂甙有类似骨架的达玛烷型绞股蓝皂甙,绞股蓝皂甙具有多种生理活性,有抗癌、抗衰老、抗溃疡、镇静、镇痛、降血脂等作用。据学者用绞股蓝提取液对人体直肠腺癌细胞系的体外抗肿瘤作用进行研究,发现绞股蓝皂甙使大肠癌细胞DNA合成降低,核分裂数减小,细胞变性坏死。此外绞股蓝皂甙可明显降低血压和外周血管、脑血管与冠状血管阻力,增加冠脉流量,减慢心率,使心脏张力时间指数下降,降低心肌耗氧量,所以绞股蓝皂甙对高血压、心脑血管痉挛性疾病及心功能不全的病人有一定益处。绞股蓝皂甙的化学结构与人参皂甙相似,且部分绞股蓝皂甙与人参皂甙相同,因而绞股蓝皂甙可作为人参代用品,增强人体免疫能力。人称绞股蓝为“南方人参”。
绞股蓝的主要有效成分为绞股蓝皂甙,绞股蓝皂甙之所以“神奇”是因为其人参皂甙类成分(84种)超过人参的数倍,其对治疗和预防高血压等心血管疾病、糖尿病、便秘、痔疮、哮喘、偏头痛、痤疮、色斑等症状有显著功效,并有较为明显的镇静、催眠、消除疲劳、增进食欲、抗衰老的作用,对肿瘤、肝炎、胃炎、胃及十二指肠溃疡、胃下垂、口腔炎、冠心病、动脉硬化、胆结石、肢体麻木、皮肤粗糙、男性不育、性功能衰退、肥胖及白发秃顶等具有较佳疗效。还可能成为21世纪人类征服心血管疾病、糖尿病、紧张症、癌症和艾滋病的主要生理活性物质。
本发明配伍科学,以酒行药势,以酒助药物有效成分的析出,经测定,每100ml本发明保健酒中含有粗多糖(以葡萄糖计)0.51mg,总皂甙(以人参皂甙Re计)0.42mg,从而能够很好地调节人体免疫功能,达到怡气健身、壮阳补肾、增强体力之目的。
本发明适宜于免疫力低下者,不适宜于孕妇及哺乳妇女、少年儿童、异体蛋白过敏者。本发明属于滋补酒,不能代替药物使用。
具体实施方式
实施例1
以1000ml、55度粮食酿造优质白酒浸泡下列重量原料药:蚂蚁50g、枸杞子150g、西洋参20g、绞股蓝150g,密封储藏15天以上,得蚁力神滋补酒。
以1000ml、55度粮食酿造优质白酒,按实施例1方法制备下列实施例,得蚁力神滋补酒。
| 拟黑多刺蚁 | 枸杞子 | 西洋参 | 绞股蓝 | |
| 实施例2 | 1 | 80 | 1 | 50 |
| 实施例3 | 20 | 50 | 10 | 80 |
| 实施例4 | 10 | 65 | 5 | 65 |
| 实施例5 | 30 | 160 | 15 | 160 |
| 实施例6 | 60 | 70 | 40 | 90 |
| 实施例7 | 50 | 150 | 25 | 150 |
| 实施例8 | 70 | 200 | 30 | 200 |
| 实施例9 | 100 | 170 | 50 | 170 |
| 实施例10 | 80 | 180 | 45 | 180 |
Claims (9)
1、一种滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁1-100g、枸杞子50-200g、西洋参1-50g、绞股蓝50-200g。
2、如权利要求1所述的滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁1-20g、枸杞子50-80g、西洋参1-10g、绞股蓝50-80g。
3、如权利要求2所述的滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁10g、枸杞子65g、西洋参5g、绞股蓝65g。
4、如权利要求1所述的滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁20-60g、枸杞子80-160g、西洋参10-40g、绞股蓝80-160g。
5、如权利要求4所述的滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁50g、枸杞子150g、西洋参25g、绞股蓝150g。
6、如权利要求1所述的滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁60-100g、枸杞子160-200g、西洋参40-50g、绞股蓝160-200g。
7、如权利要求6所述的滋补酒,其特征在于它由1000ml白酒浸泡下列中药原料制备而成:
蚂蚁80g、枸杞子180g、西洋参45g、绞股蓝180g。
8、如权利要求1-7之任一所述的滋补酒,其特征在于所述白酒为55度粮食酿造优质白酒。
9、如权利要求1-7之任一所述的滋补酒,其特征在于所述蚂蚁为拟黑多刺蚁。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100642288A CN1308016C (zh) | 2005-04-11 | 2005-04-11 | 滋补酒 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100642288A CN1308016C (zh) | 2005-04-11 | 2005-04-11 | 滋补酒 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1686398A CN1686398A (zh) | 2005-10-26 |
| CN1308016C true CN1308016C (zh) | 2007-04-04 |
Family
ID=35304440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100642288A Expired - Fee Related CN1308016C (zh) | 2005-04-11 | 2005-04-11 | 滋补酒 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1308016C (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103897940A (zh) * | 2012-12-28 | 2014-07-02 | 张钊 | 一种绞股蓝富硒保健酒及其制备方法 |
| CN104774705A (zh) * | 2014-01-11 | 2015-07-15 | 山东大学(威海) | 一种西洋参酒的制备方法 |
| CN111171999A (zh) * | 2019-12-30 | 2020-05-19 | 南京中山制药有限公司 | 一种蚂蚁保健酒及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1255361A (zh) * | 1999-09-10 | 2000-06-07 | 刘福明 | 一种多功能保健酒 |
-
2005
- 2005-04-11 CN CNB2005100642288A patent/CN1308016C/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1255361A (zh) * | 1999-09-10 | 2000-06-07 | 刘福明 | 一种多功能保健酒 |
Non-Patent Citations (3)
| Title |
|---|
| 蚂蚁制剂药理研究的新进展 何颖等,时珍国医国药,第14卷第2期 2003 * |
| 蚂蚁制剂药理研究的新进展 何颖等,时珍国医国药,第14卷第2期 2003;蚂蚁资源的利用和保护 蒋三俊,特种经济动植物,第5卷 1999 * |
| 蚂蚁资源的利用和保护 蒋三俊,特种经济动植物,第5卷 1999 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1686398A (zh) | 2005-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106214989A (zh) | 一种抗衰老、改善记忆力的鹿血保健药酒及其制备方法 | |
| CN102763873A (zh) | 天麻营养饮料及其生产工艺 | |
| CN104673578B (zh) | 具有保健功效的sod葡萄酒及制备方法 | |
| CN107904103A (zh) | 一种铁皮石斛保健酒及其制备方法和应用 | |
| CN102920806B (zh) | 安神降压中药茶 | |
| CN106497751A (zh) | 一种黄精牡蛎复合配制酒及制备方法 | |
| CN101467673A (zh) | 一种复方人参保健品及其制备方法 | |
| CN108524673A (zh) | 一种中药组合物及其应用 | |
| CN108277138A (zh) | 一种保健养生酒及其制备方法 | |
| CN106579419A (zh) | 一种缓解疲劳、恢复体力、补充能量的功能食品组合物 | |
| CN1308016C (zh) | 滋补酒 | |
| CN107158299B (zh) | 一种具有增强学习记忆力功能的组合物及其制备方法 | |
| CN101391001A (zh) | 预防高原反应的中药组合物及其制备方法 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
| CN108684992A (zh) | 一种能快速醒酒的植物配方的解酒饮料及其制备方法 | |
| CN103599259B (zh) | 一种具有降血糖作用的傣药提取物制备及其应用 | |
| CN108159191A (zh) | 壮阳健肾的组合物、用途和口服液及其制备方法 | |
| CN107805577A (zh) | 一种金线莲养生酒的制备方法 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN103451067B (zh) | 抗疲劳保健药酒 | |
| LU508704B1 (en) | Kidney tonifying and yang strengthening health care composition and preparation method thereof | |
| CN106036269A (zh) | 一种含南瓜酵素的饮料及其制备方法 | |
| CN105214068B (zh) | 一种治疗小儿多发性抽动症的营养组合物及其制备方法 | |
| CN101003776A (zh) | 彝方养生酒及其制备方法 | |
| CN103371423A (zh) | 一种降火滋阴补气的植物功能饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |